Methylene Blue (Low-dose)

Methylene blue is a synthetic compound that research suggests may support cellular energy production and cognitive function when used at low doses (0.5-4mg daily). Studies indicate it works primarily by enhancing mitochondrial function, accepting electrons in the cellular respiratory chain and potentially improving ATP synthesis. Clinical research has explored its effects on memory performance and brain metabolism in healthy adults.

Research suggests low-dose methylene blue may have neuroprotective properties, with studies showing potential benefits for tau protein aggregation and oxidative stress reduction. Small human trials have investigated its effects on cognitive performance, with some indicating improvements in short-term memory tasks and brain activation patterns. However, the evidence base remains limited, with most studies involving small sample sizes.

While generally well-tolerated at low doses, methylene blue requires careful consideration due to significant drug interactions, particularly with psychiatric medications. Studies emphasize the importance of pharmaceutical-grade preparations and medical supervision, as the compound can cause serious adverse effects in individuals with certain genetic conditions or when combined with specific medications.